SLAMF6 and neoplasm: A recent study in melanoma has also shown α-SMA+ CAF-derived MMP2 may cleave two ligands of the NK-activating receptor at the surface of tumor cells and consequently reduce the NKG2D-dependent cytotoxicity against melanoma tumor cells [8].